Format

Send to

Choose Destination
Clin Chem. 2015 Jan;61(1):41-9. doi: 10.1373/clinchem.2014.222687. Epub 2014 Nov 24.

Next generation sequencing in clinical diagnostics: experiences of early adopters.

Author information

1
Associate Professor of Pathology, University of Utah School of Medicine, Salt Lake City, UT; Medical Director, Molecular Genetics, ARUP Laboratories, Salt Lake City, UT; lyone@aruplab.com.
2
Professor and Chair, Department of Laboratory Medicine and Pathology and President and CEO, Mayo Medical Laboratories, Mayo Clinic, Rochester, MN; Current affiliation: Quest Diagnostics (10/1/14);
3
Managing Director, GeneDx, Gaithersburg, MD;
4
Assistant Director, Pathology Translational Research Laboratory, Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, Oregon;
5
Director, Center for Clinical and Translational Metagenomics, Brigham & Women's Hospital and Associate Professor of Pathology, Harvard Medical School, Boston, MA;
6
Chief Medical Officer, 23andMe, Inc. and.
7
Associate Professor, Pathology and Immunology, Pediatrics and Genetics, Director of Cytogenomics and Molecular Pathology, Washington University School of Medicine, St. Louis, MO;
8
Department of Pathology & Knight Cancer Institute, Oregon Health & Science University, Portland, OR;
9
Department of Pathology and Laboratory Medicine. Women & Infants Hospital, Alpert Medical School at Brown University, Providence, RI.
PMID:
25421800
DOI:
10.1373/clinchem.2014.222687
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center